Grant Wallace
Clinical Cardiac Electrophysiology · Lincoln, NENPI 1831516491
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.0%), grants and consulting fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 49.4% of the total. 2025 is the largest year on record at $41,140, more than ten times the $3,750 reported in 2021.
Across 76 payments — averaging $780.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$29K
- Boston Scientific$15K
- Medtronic$8K
- Impulse Dynamics (USA) Inc.$7K
- Biosense Webster, Inc.$216
- Cardiva Medical, Inc.$109
- plus $135 from 4 others
Across 13 payments — averaging $3080.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Impulse Dynamics (USA) Inc.$40K
What the payments were for
- Consulting fees$13,87323%
- Speaking & faculty fees$23,12039%
- Grants$14,00024%
- Travel & lodging$4,4708%
- Food & beverage$3,8476%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 6 | $29,308 |
| Boston Scientific | 39 | $15,181 |
| Medtronic | 16 | $7,578 |
| Impulse Dynamics (USA) Inc. | 6 | $6,783 |
| Biosense Webster, Inc. | 2 | $216 |
| Cardiva Medical, Inc. | 1 | $109 |
| Medical Device Business Services, Inc. | 1 | $94 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Pfizer | 1 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACUSON Origin Diagnostic Ultrasound System$29,177
- EMBLEM MRI S-ICD$3,969
- EMBLEM$3,750
- Farapulse$3,667
- INGEVITY$629
- COBALT DR MRI SURESCAN$168
- Micra$162
- GENERAL - THERAPIES$151
- AZURE XT DR MRI SURESCAN$139
- WATCHMAN Access System$135
- QDOT MICRO$120
- Rhythmia Mapping System$111
- Cardiva VASCADE MVP VVCS 6-12F$109
- CLARIA MRI QUAD CRT-D SURESCAN$104
- WATCHMAN FLX$102
How this compares
$59,310 in reported general payments places this provider in the 75th percentile of 21 clinical cardiac electrophysiology providers in Nebraska.
See all clinical cardiac electrophysiology providers in Nebraska →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 46 | $38,615 |
| XareltoRivaroxaban | 24 | $27,036 |
| Amiodarone Hcl | 93 | $1,270 |
| Metoprolol Succinate | 70 | $1,063 |
| Flecainide Acetate | 40 | $963 |
| SotalolSotalol Hcl | 15 | $827 |
| Colchicine | 18 | $258 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 17 | $179 |
| Pantoprazole Sodium | 19 | $142 |
| Lisinopril | 14 | $84 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $14 | $38,61546 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 21 clinical cardiac electrophysiology providers in Nebraska.
Other clinical cardiac electrophysiology in Lincoln
- Peter GallagherLincoln$48K
- Stephen AckermanLincoln$45K
- Walid KutayliLincoln$13K
- Andrew MerlissLincoln$158
- Brian KimKearney$455K
- Hussam AbuissaOmaha$162K
- Jeffrey MahoneyOmaha$118K
- Shane TsaiOmaha$68K
- Jason PayneOmaha$59K
- Matthew SorensenOmaha$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.